Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab

SIMPLE SUMMARY: Treatment options for intermediate- or advanced-stage hepatocellular carcinoma include trans-arterial radioembolization of the whole liver and systemic therapy. While no significant difference in overall survival has been reported for patients receiving radioembolization or sorafenib...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeschke, Matthias, Ludwig, Johannes M., Leyh, Catherine, Pabst, Kim M., Weber, Manuel, Theysohn, Jens M., Lange, Christian M., Herrmann, Ken, Schmidt, Hartmut H. -J., Jochheim, Leonie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486761/
https://www.ncbi.nlm.nih.gov/pubmed/37686549
http://dx.doi.org/10.3390/cancers15174274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486761/
https://www.ncbi.nlm.nih.gov/pubmed/37686549
http://dx.doi.org/10.3390/cancers15174274

Ejemplares similares